Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan · Delayed Price · Currency is TWD 135.50
-6.00 (-4.24%)
At close: Feb 11, 2026
TPEX:3218 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 987.4 | 1,065 | 1,045 | 850.53 | 595.43 | 483.21 |
Depreciation & Amortization | 538 | 518.05 | 441.77 | 367.85 | 315.1 | 260.46 |
Other Amortization | 2.7 | 3.44 | 4.38 | 4.41 | 4.42 | 3.5 |
Loss (Gain) From Sale of Assets | 4.51 | 8.92 | 1.37 | 2.22 | 0.22 | -3.28 |
Loss (Gain) From Sale of Investments | 166.94 | 100.22 | - | - | - | - |
Provision & Write-off of Bad Debts | -0.71 | 2.44 | 4.36 | 7.65 | 0.32 | 0.01 |
Other Operating Activities | 6.32 | -20.24 | 65.66 | 83.06 | 38.42 | 45 |
Change in Accounts Receivable | 21.77 | 16.1 | -6.76 | -54.54 | -158.12 | -35 |
Change in Inventory | -51.19 | 1.8 | -89.85 | -111.63 | -47.32 | -1.27 |
Change in Accounts Payable | -23.88 | -44.24 | 57.76 | 44.06 | 87.56 | 46.46 |
Change in Other Net Operating Assets | -21.03 | 20.85 | 29.82 | 74.57 | 75.74 | 27.98 |
Operating Cash Flow | 1,631 | 1,672 | 1,554 | 1,268 | 911.77 | 827.08 |
Operating Cash Flow Growth | -0.18% | 7.63% | 22.51% | 39.09% | 10.24% | 97.31% |
Capital Expenditures | -497.14 | -434.65 | -472.53 | -489.7 | -324.44 | -295.15 |
Sale of Property, Plant & Equipment | 0.39 | 0.86 | 0.08 | 0.12 | 0.07 | 11.9 |
Cash Acquisitions | - | - | - | - | - | -8.16 |
Sale (Purchase) of Intangibles | -1.57 | -2.45 | -1.68 | -3.14 | -4.26 | -3.36 |
Investment in Securities | 90.39 | -1,046 | -1.74 | -70.81 | -44.06 | -122.78 |
Other Investing Activities | -2.71 | -1.93 | -1.08 | -1.14 | -7.11 | -1.66 |
Investing Cash Flow | -410.63 | -1,484 | -476.95 | -564.66 | -379.81 | -419.2 |
Short-Term Debt Issued | - | 82.52 | 8.85 | - | - | 100 |
Long-Term Debt Issued | - | - | - | - | 23.88 | - |
Total Debt Issued | -205.5 | 82.52 | 8.85 | - | 23.88 | 100 |
Short-Term Debt Repaid | - | - | - | - | -176.49 | - |
Long-Term Debt Repaid | - | -185.43 | -177.84 | -164.22 | -140.03 | -117.37 |
Total Debt Repaid | -240.53 | -185.43 | -177.84 | -164.22 | -316.52 | -117.37 |
Net Debt Issued (Repaid) | -446.03 | -102.91 | -168.99 | -164.22 | -292.64 | -17.37 |
Common Dividends Paid | -635.44 | -593.07 | -479.58 | -380.62 | -319.72 | -152.25 |
Other Financing Activities | 10.04 | -67.06 | -62.09 | 5 | 0.03 | 5 |
Financing Cash Flow | -1,071 | -763.04 | -710.65 | -539.83 | -612.33 | -164.62 |
Foreign Exchange Rate Adjustments | -14.29 | 19.41 | -6.46 | 5.14 | -1.45 | 0.61 |
Net Cash Flow | 134.48 | -555.69 | 359.53 | 168.83 | -81.81 | 243.87 |
Free Cash Flow | 1,134 | 1,237 | 1,081 | 778.47 | 587.33 | 531.93 |
Free Cash Flow Growth | -7.34% | 14.46% | 38.87% | 32.55% | 10.41% | 189.10% |
Free Cash Flow Margin | 26.93% | 29.27% | 26.48% | 22.28% | 22.32% | 25.91% |
Free Cash Flow Per Share | 13.34 | 14.56 | 12.73 | 9.17 | 6.92 | 6.27 |
Cash Interest Paid | 7.11 | 5.05 | 1.47 | 1.21 | 2.47 | 3.78 |
Cash Income Tax Paid | 305.96 | 283.54 | 220.7 | 165.62 | 132.78 | 77.82 |
Levered Free Cash Flow | 831.04 | 922.06 | 820.41 | 574.26 | 411.54 | 410.63 |
Unlevered Free Cash Flow | 847.09 | 935.15 | 830.3 | 582.73 | 419.77 | 417.46 |
Change in Working Capital | -74.33 | -5.49 | -9.04 | -47.55 | -42.14 | 38.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.